Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Tumor targeted delivery of immunomodulators by nanoplymers

A technology of nanopolymers and immunomodulators, applied in antineoplastic drugs, drug combinations, capsule delivery, etc.

Inactive Publication Date: 2013-03-27
BOARD OF RGT THE UNIV OF TEXAS SYST
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, systemic injection of CpG leads to the activation of pDC cells in major immune organs and depletes this important type of antitumor cell pool outside the tumor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Tumor targeted delivery of immunomodulators by nanoplymers
  • Tumor targeted delivery of immunomodulators by nanoplymers
  • Tumor targeted delivery of immunomodulators by nanoplymers

Examples

Experimental program
Comparison scheme
Effect test

Embodiment I

[0220] Prophetic Example I, Assessment of Innate and Adaptive Immunity Induced by CpG and PG-Based Nanoconstructs Following Intratumoral Injection.

[0221] In vivo uptake of pDCs. 10 mice / group x 12 groups (except saline) x 3 time points = 360 mice

[0222] GFP transgenic mice. 10 mice / group x 12 groups = 120 transgenic mice

[0223] table 3

[0224] For Prophetic Example II, total: 300 C57BL / 6 mice, 140 transgenic mice

[0225]

[0226] Prophetic Example II, Evaluation of In Vitro and In Vivo Immunostimulatory Activity of Targeted CpG and Tyrosinase-Activatable CpG Nanoconstructs

[0227] Uptake of pDC: 10 mice / group x 7 groups (excluding tyrosinase-knockout tumors) x 2 injection routes = 140 mice

[0228] GFP transgenic mice: 10 mice / group x 7 groups x 2 injection routes = 140 transgenic mice

[0229] Prophetic Example II, Antitumor Activity: 10 mice / group x 16 groups = 160 mice .

[0230] Table 3a

[0231] For Prophetic Example III

[0232] Nano-CpG (...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Nanoconstructs having three components: (1) biodegradable nanopolymers and nanoparticles, (2) immunodrugs such as CpG, and a (3) tumor binding device, which are actively targeted to tumor cells such as melanoma cells through receptor-mediated uptake and methods of using the same are described. Antitumor immunity is further enhanced by combination of PG-CpG nanoconstructs with agonists of positive costimulatory signals and inhibitors of negative immune regulatory signals.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Patent Provisional Application Serial No. 61 / 301,252, filed February 4, 2009. This application is hereby incorporated by reference in its entirety. [0003] Statement Regarding Federal Funding for Research or Development [0004] none. [0005] Names of parties in the joint research agreement [0006] none. [0007] Reference Sequence Listing [0008] none. field of invention [0009] Nanoconstructs comprising biodegradable polymers conjugated to tumor-binding ligands and antibodies that can target tumors and enhance residency at tumor sites are described. Anti-tumor immunity can be further enhanced by combining nanoconstructs with agonists of positive co-stimulatory signals and inhibitors of negative immunoregulatory signals. Background of the invention [0010] Melanoma is the deadliest of the skin cancers because of its propensity to spread widely throughout the body. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48A61K47/30A61K39/395A61K9/127A61K9/48A61P35/00
CPCA61K47/48238A61K47/48315A61K47/4833A61K47/62A61K47/645A61K47/646A61P35/00
Inventor 周大鹏李春P.吴
Owner BOARD OF RGT THE UNIV OF TEXAS SYST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com